Introduction
This Modern Slavery and Human Trafficking Statement is a response to Section 54(1), Part 6 of the Modern Slavery Act 2015 and relates to actions and activities for the financial year ending 28 February 2022.
MEDICARE HEALTH PRODUCTS LTD (‘the Company’, ‘we’, ‘us’ or ‘our’) is committed to preventing slavery and human trafficking violations in its own operations, its supply chain, and its products. We have zero-tolerance towards slavery and require our supply chain to comply with our values.
Organisational structure
MEDICARE HEALTH PRODUCTS LTD has business operations in the United Kingdom.
We operate in the healthcare sector. The nature of our supply chains is as follows: We work with a number of key direct suppliers, who provide us with goods, such as equipment for our premises, and services, such as outsourced business processes, IT software and marketing services.
For more information about the Company, please visit our website: mediclare.co.uk.
Due Diligence
As part of our efforts to monitor and reduce the risk of slavery and human trafficking occurring in our supply chains, we have adopted the following due diligence procedures:
- Internal supplier audits.
- External supplier audits.
- Checking certain suppliers with external third parties for any slavery or human trafficking risks.
Our due diligence procedures aim to:
- Identify and action potential risks in our business and supply chains.
- Monitor potential risks in our business and supply chains
- Reduce the risk of slavery and human trafficking occurring in our business and supply chains.
Risk and compliance
The Company has evaluated the nature and extent of its exposure to the risk of slavery and human trafficking occurring in its UK supply chain through:
- Creating an annual risk profile for key suppliers.
We do not consider that we operate in a high-risk environment because majority of our supply chain is based in the UK and in low-risk industries, such as retaling the goods
We do not tolerate slavery and human trafficking in our supply chains. Where there is evidence of failure to comply with our procedures by any of our suppliers, we will seek to terminate our relationship with that supplier immediately.
Effectiveness
The Company uses Key Performance Indicators (KPIs) to measure its effectiveness and ensure that slavery and human trafficking is not taking place in its business and supply chains. These KPIs are as follows:
- We will contact suppliers to enquire about their modern slavery practices every 3 months.
Next steps
In the next financial year, we intend to take the following steps to tackle slavery and human trafficking by:
- We will keep to contact suppliers to enquire about their modern slavery practices
The statement was approved by the board of directors.
___________________________
Mehmet Erhan Atilla, Director
MEDICARE HEALTH PRODUCTS LTD
___________________________
Date 01.05.2022
